Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-39187
J Biol Chem 2009 Mar 13;28411:6832-40. doi: 10.1074/jbc.M808988200.
Show Gene links Show Anatomy links

Deleted in breast cancer 1, a novel androgen receptor (AR) coactivator that promotes AR DNA-binding activity.

Fu J , Jiang J , Li J , Wang S , Shi G , Feng Q , White E , Qin J , Wong J .


???displayArticle.abstract???
Androgen receptor (AR) plays a critical role in development and maintenance of male reproductive functions and the etiology of prostate cancer. As a ligand-regulated transcription factor, identification and characterization of AR coregulators are essential for understanding the molecular mechanisms underlying its diverse biological functions. Here we reported the identification of a novel AR coactivator, deleted in breast cancer 1 (DBC1), through a biochemical approach. DBC1 interacts with AR in a ligand-stimulated manner and facilitates AR transcriptional activation in transfected cells as well as in Xenopus oocytes. In in vitro gel shift experiments, recombinant DBC1 drastically enhanced AR DNA-binding activity. Expression of DBC1 also enhanced the binding of AR to chromatinized template in vivo, whereas knockdown of DBC1 impaired the binding of AR to endogenous prostate-specific antigen (PSA) gene in the prostate cancer cell line LNCaP. Thus, our data identify DBC1 as a novel AR coactivator.

???displayArticle.pubmedLink??? 19126541
???displayArticle.pmcLink??? PMC2652261
???displayArticle.link??? J Biol Chem


Species referenced: Xenopus
Genes referenced: ar

References [+] :
Almouzni, Replication-coupled chromatin assembly is required for the repression of basal transcription in vivo. 1993, Pubmed, Xenbase